Older age, dyspnea, longer duration of illness, comorbidities, and use of oxygen hurt quality of life for those with chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD) is considered to be a significant challenge and remains a leading cause of morbidity and mortality worldwide. A recent study, which evaluated the impact of selected sociodemographic and clinical factors on a patient’s quality of life (QOL), found that COPD patients’ age decreases the levels of both QOL and level of illness acceptance (LIA), while factors including dyspnea, longer duration of illness, comorbidities, oxygen therapy undertaking, affect the deterioration of QOL.
The study evaluated 100 patients who had COPD for at least half a year and were treated at a clinic at Wroclaw Medical University in Poland. In order to assess QOL and LIA, the researchers used standardized questionnaires, including Short Form-36 Health Survey, Saint George’s Respiratory Questionnaire, Acceptance of Illness Scale, and COPD Author’s Questionnaire.
“The life of people with a chronic disease changes dramatically and leads to significant deterioration in its quality. Comparing the needs with existing reality, especially in chronic diseases, occurs on many levels of quality of life (QOL),” explained the authors. “The studies conducted on the QOL are an attempt to assess the influence of disease on all areas of human life. The progress of medicine that has taken place in recent years has not significantly reduced morbidity and mortality resulting from chronic diseases.”
The main results included:
The researchers noted that assessment and identification of selected sociodemographic and clinical factors in COPD patients are likely to improve the QOL and LIA and optimize management, while also leading to better patient outcomes.
“Today, increasing attention is paid to QOL in chronic diseases of the respiratory system. Health-related QOL studies confirm that people with COPD require holistic approach by health care workers who should take into account not only the medical parameters but also other indicators that influence the overall well-being, that is, mental status or socioeconomic status,” concluded the authors. “Thus, it is necessary to carry out studies detecting potential determinants affecting the assessment of QOL in COPD patients, and identifying these factors will be helpful in planning comprehensive care plan for this group of patients.”
Future studies are necessary to evaluate the number and severity of comorbidities that may influence the results of relationships involved in the duration of the disease.
Reference
Rosińczuk J, Przyszlak M, Uchmanowicz I. Sociodemographic and clinical factors affecting the quality of life of patients with chronic obstructive pulmonary disease. [published online September 12, 2018]. nt J Chron Obstruct Pulmon Dis. doi: 10.2147/COPD.S165714.
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More